Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy

Abstract

Bevacizumab is thought to normalize tumor vasculature and restore the blood-brain barrier, decreasing enhancement and peritumoral edema. Conventional measurements of tumor response rely upon dimensions of enhancing tumor. After bevacizumab treatment, glioblastomas are more prone to progress as nonenhancing tumor. The RANO (Response Assessment in Neuro… (More)
DOI: 10.1007/s11910-011-0179-x

3 Figures and Tables

Topics

  • Presentations referencing similar topics